Sudarshan Chemical Industries LtdQ3 FY25Chemicals & Petrochemicals

Sudarshan Chemical Industries Ltd

Q3 FY25 Earnings Call Analysis

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Revenue guidance

Category 3

→The company expects a temporary setback in demand due to high customer inventories and external factors, impacting near-term sales.
→Q3 FY '26 is expected to be subdued, with a possible slight dip or flat quarter-on-quarter performance.
→Strong rebound anticipated from Q4 FY '26 onward, driven by restocking as customers deplete inventories.
→3- to 4-year growth projections remain unchanged, aiming for sustainable long-term expansion.
→Domestic pigment business expected to have strong performance in the second half of FY '26.
→Export business to remain subdued in Q3 but pick up from Q4 onwards.
→Value capture initiatives and operational improvements will support growth.
→Innovation partnerships and R&D engagements, including with top customers (Apple, Samsung), are expected to contribute to future revenue growth with a lead time of over a year.
→Capacity utilization aligned with capex plans, with possibilities of acceleration enhancing volume growth.

Category 3

→Sudarshan Chemical Industries maintains its 3- to 4-year growth projections despite short-term setbacks due to external demand conditions and high customer inventory.
→For FY '26, the acquired group's EBITDA guidance was revised down to €25-30 million, with Q3 expected subdued but strong recovery and demand pickup anticipated from Q4 onwards.
→The legacy pigment business expects a return to 14-15% EBITDA margins following temporary dips caused by lower production and operating leverage.
→Fixed costs present short-term challenges but also opportunities for cost reduction and value capture initiatives.
→Working capital efficiency targeted to improve, aiming to reduce from 26.2% to 24% turnover by FY '27.
→R&D and innovation efforts with major clients like Apple and Samsung aim to create long-term revenue streams beyond a year's lead time.
→Integration of Heubach technology and cost synergies from relocating manufacturing to India are expected to support EBITDA growth to $90-100 million by FY '28-29.

Get access to all 5 sections — revenue, margin, fundraise, orderbook, and capex — for Sudarshan Chemical Industries Ltd and 1,400+ other companies.

→The transcript from the Sudarshan Chemical Industries Limited Q2 FY '26 earnings call does not mention any plans for current or future fundraising through debt or equity.
→There is no discussion of new borrowings, equity issuance, or capital raising initiatives in the provided document.
→The focus is primarily on business performance, integration of acquisitions, cost optimization, working capital management, and growth outlook.
→Management emphasizes maintaining robust financials and managing working capital but does not indicate plans to raise funds externally.

Yes

→Sudarshan Chemical Industries has observed that global key accounts had stocked up significantly due to uncertainties, leading to higher customer inventory levels than anticipated.
→This stocking resulted in subdued demand and impacted Q2 sales.
→Management has engaged deeply with these key accounts, who have assured that demand will revive starting January.
→Some customers have already placed orders for January onwards, signaling a pickup in the order book.
→The company expects Q4 to be the strongest quarter, with improved order inflows and higher demand leading to better sales and EBITDA performance.
→Overall, the current order book shows positive signs for Q4, supported by customer re-stocking after a temporary demand slowdown.

Yes

→The company completed a significant capex investment of roughly INR 700 crores about 3-4 years ago.
→Capacity utilization from this capex is progressing as planned and may accelerate due to the new market situation.
→There is a project underway to move some products from higher-cost manufacturing sites (like Germany) to India, which will boost benefits.
→The integration of Heubach and Sudarshan includes setting up a Global Capability Center (GCC) and implementing ONE SAP for better operational leverage and cost reduction.
→Value capture initiatives involve operations, supply chain optimization, supplier landscape rationalization, and cost-saving measures.
→The company is investing in R&D and technical teams to innovate in partnership with customers like Apple and Samsung.
→Future capex or strategic investments are not explicitly detailed but focus seems on integration, optimization, and innovation programs.

How does Sudarshan Chemical Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Sudarshan Chemical Industries Ltd

Rev 3Mar 3

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Sudarshan Chemical Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.